Medasense offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedication.
Medasense has raised €15M across 1 funding round, most recently a Series C round in Sep 2020. Based in Ramat Gan, Israel; founded 2008; active in Software. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-22 | Series C | €15M |
| — |
| View deal → |
